|
|
|
27.12.25 - 01:06
|
Need for speed: Chinese researchers unveil new technique for near-instant AI video creation (SCMP)
|
|
|
A new technique called TurboDiffusion claims to be able to accelerate artificial intelligence video-generation speeds by up to 200 times at scale, without compromising overall image quality, according to a recently published paper.
The technique reduced the time needed to generate a five-second, standard-definition video clip from more than three minutes to just 1.9 seconds – a nearly 100 times acceleration – when it was tested on a consumer-grade system with Nvidia's RTX 5090 graphics......
|
|
|
|
|
|
|
|
|
|
|
26.12.25 - 22:00
|
Missed Out on NVIDIA? My Best AI Stock to Buy and Hold (Fool)
|
|
|
The AI boom is bigger than one stock, and this lesser-known name is quietly turning NVIDIA-driven demand into real growth.
The post Missed Out on NVIDIA? My Best AI Stock to Buy and Hold appeared first on The Motley Fool Canada....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26.12.25 - 18:09
|
Nvidia Stock Climbs As The King Of AI Defends Its Throne (Benzinga)
|
|
|
Rosenblatt sees Nvidia's deal with Groq as a key move to maintain its dominance in the AI indutry.
Latest Ratings for NVDA
DateFirmActionFromTo Mar 2022Goldman SachsReinstatesNeutral Feb 2022Summit Insights GroupDowngradesBuyHold Feb 2022MizuhoMaintainsBuy
View More Analyst Ratings for NVDA
View the Latest Analyst Ratings
read more...
|
|
|
|
|
|
|
|
|
|
|
26.12.25 - 16:01
|
Stocks Touch Record as Nvidia Gains on AI Licensing Deal (Bloomberg)
|
|
|
US stocks advanced toward a fresh record high in thin holiday trading, as yields on 10-year Treasuries slipped and investors shifted attention toward commodities. Nvidia Corp. climbed as analysts viewed a licensing deal with artificial intelligence startup Groq positively....
|
|
|
|
|
26.12.25 - 15:48
|
Nvidia Up on AI Licensing Deal, Biohaven Down on Study Results, Coforge Up (Bloomberg)
|
|
|
- Shares of Nvidia (NVDA) edge higher in the premarket session as the company agreed to a licensing deal with artificial intelligence startup Groq.
- Shares of Indian technology services provider Coforge Ltd. (COFORGE IN) declined ahead of the US market open after the company agreed to buy Encora at an enterprise value of $2.35 billion in an all-stock deal.
- Shares of Biohaven (BHVN) fell as much 14 percent in US premarket trading after a mid-stage study of the company's experimental drug BHV-7000 for the treatment of major depressive disorder missed the primary endpoint. Trends favoring BHV-7000 were observed in some clinically relevant subgroups, including participants with more severe depression at screening and baseline, on primary and secondary outcome measures. (Source: Bloomberg)...
|
|